XML 60 R42.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2020
Schedule of Income Before Income Taxes
a.
Income (loss) before income taxes:
 
    
Year ended December 31,
 
    
2020
    
2019
    
2018
 
    
(U.S. $ in millions)
 
Parent Company and its Israeli subsidiaries
   $ 947      $ 542      $ 1,022  
Non-Israeli subsidiaries
     (5,353      (1,807      (3,618
    
 
 
    
 
 
    
 
 
 
     $ (4,406    $ (1,265    $ (2,596
    
 
 
    
 
 
    
 
 
 
Schedule of the Provision for Income Taxes
b.
Income taxes:
 
    
Year ended December 31,
 
    
2020
    
2019
    
2018
 
    
(U.S. $ in millions)
 
In Israel
   $ 60      $ 107      $ 131  
Outside Israel
     (228      (385      (326
    
 
 
    
 
 
    
 
 
 
     $ (168    $ (278    $ (195
    
 
 
    
 
 
    
 
 
 
Current
   $ 182      $ 885      $ 700  
Deferred
     (350      (1,163      (895
    
 
 
    
 
 
    
 
 
 
     $ (168    $ (278    $ (195
    
 
 
    
 
 
    
 
 
 
Accumulated Other Comprehensive Income/(Loss) (Net of Tax)
    
2020
   
2019
   
2018
 
    
(U.S. $ in millions)
 
Income (Loss) before income taxes
  
$
(4,406   $ (1,265   $ (2,596
Statutory tax rate in Israel
     23.0     23.0     23.0
    
 
 
   
 
 
   
 
 
 
Theoretical provision for income taxes
   $ (1,013   $ (291   $ (597
Increase (decrease) in the provision for income taxes due to:
                        
The Parent Company and its Israeli subsidiaries - Mainly tax benefits arising from reduced tax rates under benefit programs
     (183     (44     (134
Non-Israeli subsidiaries, including impairments *
     1,369       (115     381  
U.S. Tax Cuts and Jobs Act effect
                     97  
Increase (decrease) in other uncertain tax positions—net
     (341     172       58  
    
 
 
   
 
 
   
 
 
 
Effective consolidated income taxes
   $ (168   $ (278   $ (195
    
 
 
   
 
 
   
 
 
 
 
*
In 2020 and 2018, income before income taxes includes goodwill impairment in
non-Israeli
subsidiaries that did
 
not have a corresponding tax effect.
Schedule of Deferred Income Taxes
c.
Deferred income taxes:
 
    
December 31,
 
    
2020
    
2019
 
    
(U.S. $ in millions)
 
Long-term deferred tax assets (liabilities), net:
        
Inventory related
   $ 212      $ 144  
Sales reserves and allowances
     173        198  
Provision for legal settlements
     235        260  
Intangible assets (*)
     (1,064      (1,733
Carryforward losses and deductions and credits (**)
     2,176        1,689  
Property, plant and equipment
     (142      (170
Deferred interest
     527        648  
Provisions for employee related obligations
     107        106  
Other
     54        122  
    
 
 
    
 
 
 
       2,278        1,264  
Valuation allowance—in respect of carryforward losses and deductions that may not be utilized 
     (2,547      (1,974
    
 
 
    
 
 
 
     $ (269    $ (710
    
 
 
    
 
 
 
 
(*)
The decrease in deferred tax liability is mainly due to impairment and amortization.
(**)
The amounts are shown after reduction for unrecognized tax benefits of $ 63 million and $115 million as of December 31,
2020
and
2019
, respectively.
  
This amount represents the tax effect of gross carryforward losses and deductions with the following expirations:
2021
-
2022
—$79 million;
2023
-
2029
—$663 million;
2030
and thereafter—$171 million. The remaining balance—$1,327 million—can be utilized with no expiration date.
Schedule of Deferred Tax Assets and Liabilities By Report Caption
The deferred income taxes are reflected in the balance sheets among:
 
    
December 31,
 
    
2020
    
2019
 
    
(U.S. $ in millions)
 
Long-term assets—deferred income taxes
     695        386  
Long-term liabilities—deferred income taxes
     (964      (1,096
    
 
 
    
 
 
 
     $ (269    $ (710
    
 
 
    
 
 
 
Schedule of Unrecognized Tax Benefits
d.
Uncertain tax positions:
The following table summarizes the activity of Teva’s gross unrecognized tax benefits:
 
    
Year ended December 31,
 
    
2020
    
2019
    
2018
 
    
(U.S. $ in millions)
 
Balance at the beginning of the year
   $ 1,223      $ 1,072      $ 1,034  
Increase
(decrease) 
related to prior year tax positions, net
     (238      23        76  
Increase related to current year tax positions
     10        246        11  
Decrease related to settlements with tax authorities and lapse of applicable statutes of limitations
     (105      (118      (49
Other
     (2      —          —    
    
 
 
    
 
 
    
 
 
 
Balance at the end of the year
   $ 888      $ 1,223      $ 1,072